US Patent Issued to THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH on March 31 for "Haematopoietic stem cell treatment" (British Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,589,115, issued on March 31, was assigned to THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (Edinburgh, Great Britain).

"Haematopoietic stem cell treatment" was invented by Kamil Romuald Kranc (London) and Donal O'Carroll (Edinburgh, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to modified haematopoietic stem cells, methods for preparing them, and their use in therapy; as well as methods and reagents for expanding haematopoietic stem cells (HSC) and methods for treating haematological disorders. A particular aspect relates to a method for treating a disease or condition characterised by elevated YTHDF2...